NRx Logo
  • Our Company
  • Our Science
    • Therapeutic Areas
      • Corona Virus / COVID-19
      • Psychiatry
    • Compounds Under Investigation
      • NRX-100 / NRX-101
      • ZYESAMI® (aviptadil)
      • For Physicians – Right to Try
    • NRx Pipeline
  • Pipeline
  • News & Media
  • Resources & Patient Stories
  • Investor Relations
  • Presentation
  • Careers
  • Contact Us
  • Search

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
May 19, 2022 7:20am EDT

NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. Global Investment Conference

May 16, 2022 7:12am EDT

NRx Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results

May 12, 2022 8:17am EDT

NRx Pharmaceuticals Announces Enrollment of First Patient in Phase II Study of Bipolar Depression with Sub-Acute Suicidality

May 10, 2022 8:11am EDT

NRx Pharmaceuticals to Report First Quarter 2022 Results on May 16, 2022

Apr 21, 2022 8:48am EDT

NRx Pharmaceuticals Files New Breakthrough Therapy Designation Request for ZYESAMI® (aviptadil) in Subgroup of Patients with Critical COVID-19 with Respiratory Failure that were also treated with Remdesivir and continued to progress

Apr 08, 2022 8:57am EDT

NRx Pharmaceuticals' Interim CEO and other Leaders to Present at 21st Annual Needham Virtual Healthcare Conference

Mar 31, 2022 8:17am EDT

NRx Pharmaceuticals Provides Business Update and Reports Full Year 2021 Financial Results

Mar 28, 2022 3:17am EDT

NRx Pharmaceuticals to Report Year-End 2021 Results on March 31, 2022

Mar 18, 2022 5:00am EDT

NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Chief Financial Officer and Treasurer

Mar 08, 2022 10:25pm EST

NRx Pharmaceuticals Announces Leadership Transition

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 13
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
NRx
  • Home
  • Our Company
  • Our Science
  • Pipeline
  • News & Media
  • Resources & Patient Stories
  • Investor Relations
  • Careers
  • Contact Us
  • NRx on Facebook
  • NRx on Twitter
  • NRx on Linkedin
  • Forward Looking Statement
  • Privacy Policy
  • Terms of Use
  • © 2022 NRx Pharmaceuticals, Inc.

  • NRx on Facebook
  • NRx on Twitter
  • NRx on Linkedin